The Icsbp locus is a common proviral insertion site in mature B-cell lymphomas/plasmacytomas induced by exogenous murine leukemia virus

Virology

Volumn 352, Issue 2, 2006, Pages 306-318

  Ma, Shi Liang ^a   Sørensen, Annette Balle ^a   Kunder, Sandra ^b   Sørensen, Karina Dalsgaard ^a   Quintanilla Martinez, Leticia ^b   Morris, David W ^c   Schmidt, Jörg ^b   Pedersen, Finn Skou ^a  

^a AARHUS UNIVERSITY   (Denmark)

^b INSTITUTE OF EPIDEMIOLOGY   (Germany)

^c Sagres Discovery   (United States)

Author keywords

B cell lymphomas; Common integration site; Insertional mutagenesis; Murine leukemia virus; Plasmacytoma

Indexed keywords

INTERFERON CONSENSUS SEQUENCE BINDING PROTEIN; PROTEIN; RNA;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; B CELL LYMPHOMA; CELL LINE; CELL MATURATION; CELL PROLIFERATION; CONTROLLED STUDY; EXON; GENE; GENE EXPRESSION; GENE INSERTION; GENE LOCUS; INTERFERON CONSENSUS SEQUENCE BINDING PROTEIN GENE; LYMPHOMA CELL LINE; MOUSE; MURINE LEUKEMIA VIRUS; NONHUMAN; NUCLEOTIDE SEQUENCE; PLASMACYTOMA; PRIORITY JOURNAL; PROVIRUS; T CELL LYMPHOMA; TUMOR;

ANIMALS; BASE SEQUENCE; INTERFERON REGULATORY FACTORS; LEUKEMIA VIRUS, MURINE; LYMPHOMA, B-CELL; MICE; PLASMACYTOMA; RNA, MESSENGER; RNA, NEOPLASM; VIRUS INTEGRATION;

MURINE LEUKEMIA VIRUS;

EID: 33747049749     PISSN: 00426822     EISSN: 10960341     Source Type: Journal    
DOI: 10.1016/j.virol.2006.05.006     Document Type: Article

References (71)

1. Akagi K., Suzuki T., Stephens R.M., Jenkins N.A., and Copeland N.G. RTCGD: retroviral tagged cancer gene database. Nucleic Acids Res. 32 (2004) D523-D527 (Database issue)
2. Bernal A., Pastore R.D., Asgary Z., Keller S.A., Cesarman E., Liou H.C., and Schattner E.J. Survival of leukemic B cells promoted by engagement of the antigen receptor. Blood 98 10 (2001) 3050-3057
3. Blyth K., Terry A., Mackay N., Vaillant F., Bell M., Cameron E.R., Neil J.C., and Stewart M. Runx2: a novel oncogenic effector revealed by in vivo complementation and retroviral tagging. Oncogene 20 3 (2001) 295-302
4. Bovolenta C., Driggers P.H., Marks M.S., Medin J.A., Politis A.D., Vogel S.N., Levy D.E., Sakaguchi K., Appella E., Coligan J.E., et al. Molecular interactions between interferon consensus sequence binding protein and members of the interferon regulatory factor family. Proc. Natl. Acad. Sci. U.S.A. 91 11 (1994) 5046-5050
5. Cahir-McFarland E.D., Davidson D.M., Schauer S.L., Duong J., and Kieff E. NF-kappa B inhibition causes spontaneous apoptosis in Epstein-Barr virus-transformed lymphoblastoid cells. Proc. Natl. Acad. Sci. U.S.A. 97 11 (2000) 6055-6060
6. Contursi C., Wang I.M., Gabriele L., Gadina M., O'Shea J., Morse III H.C., and Ozato K. IFN consensus sequence binding protein potentiates STAT1-dependent activation of IFNgamma-responsive promoters in macrophages. Proc. Natl. Acad. Sci. U.S.A. 97 1 (2000) 91-96
7. Darnell III J.E. Transcription factors as targets for cancer therapy. Nat. Rev., Cancer 2 10 (2002) 740-749
8. Darnell Jr. J.E., Kerr I.M., and Stark G.R. Jak-STAT pathways and transcriptional activation in response to IFNs and other extracellular signaling proteins. Science 264 5164 (1994) 1415-1421
9. Driggers P.H., Ennist D.L., Gleason S.L., Mak W.H., Marks M.S., Levi B.Z., Flanagan J.R., Appella E., and Ozato K. An interferon gamma-regulated protein that binds the interferon-inducible enhancer element of major histocompatibility complex class I genes. Proc. Natl. Acad. Sci. U.S.A. 87 10 (1990) 3743-3747
10. Driggers P.H., Elenbaas B.A., An J.B., Lee I.J., and Ozato K. Two upstream elements activate transcription of a major histocompatibility complex class I gene in vitro. Nucleic Acids Res. 20 10 (1992) 2533-2540
11. Eisenbeis C.F., Singh H., and Storb U. Pip, a novel IRF family member, is a lymphoid-specific, PU.1-dependent transcriptional activator. Genes Dev. 9 11 (1995) 1377-1387
12. Eklund E.A., and Kakar R. Recruitment of CREB-binding protein by PU.1, IFN-regulatory factor-1, and the IFN consensus sequence-binding protein is necessary for IFN-gamma-induced p67phox and gp91phox expression. J. Immunol. 163 11 (1999) 6095-6105
13. Ethelberg S., Hallberg B., Lovmand J., Schmidt J., Luz A., Grundstrom T., and Pedersen F.S. Second-site proviral enhancer alterations in lymphomas induced by enhancer mutants of SL3-3 murine leukemia virus: negative effect of nuclear factor 1 binding site. J. Virol. 71 2 (1997) 1196-1206
14. Ethelberg S., Tzschaschel B.D., Luz A., Diaz-Cano S.J., Pedersen F.S., and Schmidt J. Increased induction of osteopetrosis, but unaltered lymphomagenicity, by murine leukemia virus SL3-3 after mutation of a nuclear factor 1 site in the enhancer. J. Virol. 73 12 (1999) 10406-10415
15. Gilbert D.J., Neumann P.E., Taylor B.A., Jenkins N.A., and Copeland N.G. Susceptibility of AKXD recombinant inbred mouse strains to lymphomas. J. Virol. 67 4 (1993) 2083-2090
16. Hallberg B., Schmidt J., Luz A., Pedersen F.S., and Grundstrom T. SL3-3 enhancer factor 1 transcriptional activators are required for tumor formation by SL3-3 murine leukemia virus. J. Virol. 65 8 (1991) 4177-4178
17. Hansen G.M., Skapura D., and Justice M.J. Genetic profile of insertion mutations in mouse leukemias and lymphomas. Genome Res. 10 2 (2000) 237-243
18. Hao S.X., and Ren R. Expression of interferon consensus sequence binding protein (ICSBP) is downregulated in Bcr-Abl-induced murine chronic myelogenous leukemia-like disease, and forced coexpression of ICSBP inhibits Bcr-Abl-induced myeloproliferative disorder. Mol. Cell. Biol. 20 4 (2000) 1149-1161
19. Harada H., Fujita T., Miyamoto M., Kimura Y., Maruyama M., Furia A., Miyata T., and Taniguchi T. Structurally similar but functionally distinct factors, IRF-1 and IRF-2, bind to the same regulatory elements of IFN and IFN-inducible genes. Cell 58 4 (1989) 729-739
20. Haraguchi S., Good R.A., James-Yarish M., Cianciolo G.J., and Day N.K. Differential modulation of Th1- and Th2-related cytokine mRNA expression by a synthetic peptide homologous to a conserved domain within retroviral envelope protein. Proc. Natl. Acad. Sci. U.S.A. 92 8 (1995) 3611-3615
21. Hartley J.W., Chattopadhyay S.K., Lander M.R., Taddesse-Heath L., Naghashfar Z., Morse III H.C., and Fredrickson T.N. Accelerated appearance of multiple B cell lymphoma types in NFS/N mice congenic for ecotropic murine leukemia viruses. Lab. Invest. 80 2 (2000) 159-169
22. Holtschke T., Lohler J., Kanno Y., Fehr T., Giese N., Rosenbauer F., Lou J., Knobeloch K.P., Gabriele L., Waring J.F., Bachmann M.F., Zinkernagel R.M., Morse III H.C., Ozato K., and Horak I. Immunodeficiency and chronic myelogenous leukemia-like syndrome in mice with a targeted mutation of the ICSBP gene. Cell 87 2 (1996) 307-317
23. Jonkers J., and Berns A. Retroviral insertional mutagenesis as a strategy to identify cancer genes. Biochim. Biophys. Acta 1287 1 (1996) 29-57
24. Kakar R., Kautz B., and Eklund E.A. JAK2 is necessary and sufficient for interferon-gamma-induced transcription of the gene encoding gp91PHOX. J. Leukocyte Biol. 77 1 (2005) 120-127
25. Kessler D.S., Levy D.E., and Darnell Jr. J.E. Two interferon-induced nuclear factors bind a single promoter element in interferon-stimulated genes. Proc. Natl. Acad. Sci. U.S.A. 85 22 (1988) 8521-8525
26. Kim R., Trubetskoy A., Suzuki T., Jenkins N.A., Copeland N.G., and Lenz J. Genome-based identification of cancer genes by proviral tagging in mouse retrovirus-induced T-cell lymphomas. J. Virol. 77 3 (2003) 2056-2062
27. Klemsz M.J., McKercher S.R., Celada A., Van Beveren C., and Maki R.A. The macrophage and B cell-specific transcription factor PU.1 is related to the ets oncogene. Cell 61 1 (1990) 113-124
28. Lazo P.A., Lee J.S., and Tsichlis P.N. Long-distance activation of the Myc protooncogene by provirus insertion in Mlvi-1 or Mlvi-4 in rat T-cell lymphomas. Proc. Natl. Acad. Sci. U.S.A. 87 1 (1990) 170-173
29. Lee C.H., Melchers M., Wang H., Torrey T.A., Slota R., Qi C.F., Kim J.Y., Lugar P., Kong H.J., Farrington L., van der Zouwen B., Zhou J.X., Lougaris V., Lipsky P.E., Grammer A.C., and Morse III H.C. Regulation of the germinal center gene program by interferon (IFN) regulatory factor 8/IFN consensus sequence-binding protein. J. Exp. Med. 203 1 (2006) 63-72
30. Levi B.Z., Hashmueli S., Gleit-Kielmanowicz M., Azriel A., and Meraro D. ICSBP/IRF-8 transactivation: a tale of protein-protein interaction. J. Interferon Cytokine Res. 22 1 (2002) 153-160
31. Lovmand S., Kjeldgaard N.O., Jorgensen P., and Pedersen F.S. Enhancer functions in U3 of Akv virus: a role for cooperativity of a tandem repeat unit and its flanking DNA sequences. J. Virol. 64 7 (1990) 3185-3191
32. Lovmand J., Sorensen A.B., Schmidt J., Ostergaard M., Luz A., and Pedersen F.S. B-Cell lymphoma induction by akv murine leukemia viruses harboring one or both copies of the tandem repeat in the U3 enhancer. J. Virol. 72 7 (1998) 5745-5756
33. Lu R., Medina K.L., Lancki D.W., and Singh H. IRF-4,8 orchestrate the pre-B-to-B transition in lymphocyte development. Genes Dev 17 14 (2003) 1703-1708
34. Lund A.H., Schmidt J., Luz A., Sorensen A.B., Duch M., and Pedersen F.S. Replication and pathogenicity of primer binding site mutants of SL3-3 murine leukemia viruses. J. Virol. 73 7 (1999) 6117-6122
35. Marecki S., Riendeau C.J., Liang M.D., and Fenton M.J. PU.1 and multiple IFN regulatory factor proteins synergize to mediate transcriptional activation of the human IL-1 beta gene. J. Immunol. 166 11 (2001) 6829-6838
36. Martin-Hernandez J., Sorensen A.B., and Pedersen F.S. Murine leukemia virus proviral insertions between the N-ras and unr genes in B-cell lymphoma DNA affect the expression of N-ras only. J. Virol. 75 23 (2001) 11907-11912
37. Meraro D., Hashmueli S., Koren B., Azriel A., Oumard A., Kirchhoff S., Hauser H., Nagulapalli S., Atchison M.L., and Levi B.Z. Protein-protein and DNA-protein interactions affect the activity of lymphoid-specific IFN regulatory factors. J. Immunol. 163 12 (1999) 6468-6478
38. Mikkers H., Allen J., and Berns A. Proviral activation of the tumor suppressor E2a contributes to T cell lymphomagenesis in EmuMyc transgenic mice. Oncogene 21 43 (2002) 6559-6566
39. Mikkers H., Allen J., Knipscheer P., Romeijn L., Hart A., Vink E., and Berns A. High-throughput retroviral tagging to identify components of specific signaling pathways in cancer. Nat. Genet. 32 1 (2002) 153-159
40. Morse III H.C., Anver M.R., Fredrickson T.N., Haines D.C., Harris A.W., Harris N.L., Jaffe E.S., Kogan S.C., MacLennan I.C., Pattengale P.K., and Ward J.M. Bethesda proposals for classification of lymphoid neoplasms in mice. Blood 100 1 (2002) 246-258
41. Mucenski M.L., Taylor B.A., Jenkins N.A., and Copeland N.G. AKXD recombinant inbred strains: models for studying the molecular genetic basis of murine lymphomas. Mol. Cell. Biol. 6 12 (1986) 4236-4243
42. Nagamura-Inoue T., Tamura T., and Ozato K. Transcription factors that regulate growth and differentiation of myeloid cells. Int. Rev. Immunol. 20 1 (2001) 83-105
43. Nelson N., Marks M.S., Driggers P.H., and Ozato K. Interferon consensus sequence-binding protein, a member of the interferon regulatory factor family, suppresses interferon-induced gene transcription. Mol. Cell. Biol. 13 1 (1993) 588-599
44. Nielsen A.A., Sorensen A.B., Schmidt J., and Pedersen F.S. Analysis of wild-type and mutant SL3-3 murine leukemia virus insertions in the c-myc promoter during lymphomagenesis reveals target site hot spots, virus-dependent patterns, and frequent error-prone gap repair. J. Virol. 79 1 (2005) 67-78
45. Olsen H.S., Lovmand S., Lovmand J., Jorgensen P., Kjeldgaard N.O., and Pedersen F.S. Involvement of nuclear factor I-binding sites in control of Akv virus gene expression. J. Virol. 64 9 (1990) 4152-4161
46. Rao S., Garrett-Sinha L.A., Yoon J., and Simon M.C. The Ets factors PU.1 and Spi-B regulate the transcription in vivo of P2Y10, a lymphoid restricted heptahelical receptor. J. Biol. Chem. 274 48 (1999) 34245-34252
47. Rasmussen M.H., Sorensen A.B., Morris D.W., Dutra J.C., Engelhard E.K., Wang C.L., Schmidt J., and Pedersen F.S. Tumor model-specific proviral insertional mutagenesis of the Fos/Jdp2/Batf locus. Virology 337 2 (2005) 353-364
48. Rassa J.C., Meyers J.L., Zhang Y., Kudaravalli R., and Ross S.R. Murine retroviruses activate B cells via interaction with toll-like receptor 4. Proc. Natl. Acad. Sci. U.S.A. 99 4 (2002) 2281-2286
49. Rehli M., Poltorak A., Schwarzfischer L., Krause S.W., Andreesen R., and Beutler B. PU.1 and interferon consensus sequence-binding protein regulate the myeloid expression of the human Toll-like receptor 4 gene. J. Biol. Chem. 275 13 (2000) 9773-9781
50. Sarzotti M., Robbins D.S., and Hoffman P.M. Induction of protective CTL responses in newborn mice by a murine retrovirus. Science 271 5256 (1996) 1726-1728
51. Schiavoni G., Mattei F., Sestili P., Borghi P., Venditti M., Morse H.C., Belardelli F., and Gabriele L. ICSBP is essential for the development of mouse type I interferon-producing cells and for the generation and activation of CD8alpha(+) dendritic cells. J. Exp. Med. 196 11 (2002) 1415-1425
52. Schmidt J., Erfle V., Pedersen F.S., Rohmer H., Schetters H., Marquart K.H., and Luz A. Oncogenic retrovirus from spontaneous murine osteomas: I. Isolation and biological characterization. J. Gen. Virol. 65 Pt. 12 (1984) 2237-2248
53. Schmidt J., Luz A., and Erfle V. Endogenous murine leukemia viruses: frequency of radiation-activation and novel pathogenic effects of viral isolates. Leuk. Res. 12 5 (1988) 393-403
54. Schmidt M., Nagel S., Proba J., Thiede C., Ritter M., Waring J.F., Rosenbauer F., Huhn D., Wittig B., Horak I., and Neubauer A. Lack of interferon consensus sequence binding protein (ICSBP) transcripts in human myeloid leukemias. Blood 91 1 (1998) 22-29
55. Schmidt M., Bies J., Tamura T., Ozato K., and Wolff L. The interferon regulatory factor ICSBP/IRF-8 in combination with PU.1 up-regulates expression of tumor suppressor p15(Ink4b) in murine myeloid cells. Blood 103 11 (2004) 4142-4149
56. Sharf R., Azriel A., Lejbkowicz F., Winograd S.S., Ehrlich R., and Levi B.Z. Functional domain analysis of interferon consensus sequence binding protein (ICSBP) and its association with interferon regulatory factors. J. Biol. Chem. 270 22 (1995) 13063-13069
57. Sorensen A.B., Duch M., Jorgensen P., and Pedersen F.S. Amplification and sequence analysis of DNA flanking integrated proviruses by a simple two-step polymerase chain reaction method. J. Virol. 67 12 (1993) 7118-7124
58. Sorensen A.B., Duch M., Amtoft H.W., Jorgensen P., and Pedersen F.S. Sequence tags of provirus integration sites in DNAs of tumors induced by the murine retrovirus SL3-3. J. Virol. 70 6 (1996) 4063-4070
59. Sorensen A.B., Lund A.H., Ethelberg S., Copeland N.G., Jenkins N.A., and Pedersen F.S. Sint1, a common integration site in SL3-3-induced T-cell lymphomas, harbors a putative proto-oncogene with homology to the septin gene family. J. Virol. 74 5 (2000) 2161-2168
60. Sorensen K.D., Sorensen A.B., Quintanilla-Martinez L., Kunder S., Schmidt J., and Pedersen F.S. Distinct roles of enhancer nuclear factor 1 (NF1) sites in plasmacytoma and osteopetrosis induction by Akv1-99 murine leukemia virus. Virology 334 2 (2005) 234-244
61. Suzuki T., Shen H., Akagi K., Morse H.C., Malley J.D., Naiman D.Q., Jenkins N.A., and Copeland N.G. New genes involved in cancer identified by retroviral tagging. Nat. Genet. 32 1 (2002) 166-174
62. Tamura T., and Ozato K. ICSBP/IRF-8: its regulatory roles in the development of myeloid cells. J. Interferon Cytokine Res. 22 1 (2002) 145-152
63. Tamura T., Nagamura-Inoue T., Shmeltzer Z., Kuwata T., and Ozato K. ICSBP directs bipotential myeloid progenitor cells to differentiate into mature macrophages. Immunity 13 2 (2000) 155-165
64. Tanaka N., Kawakami T., and Taniguchi T. Recognition DNA sequences of interferon regulatory factor 1 (IRF-1) and IRF-2, regulators of cell growth and the interferon system. Mol. Cell. Biol. 13 8 (1993) 4531-4538
65. Taniguchi T., Ogasawara K., Takaoka A., and Tanaka N. IRF family of transcription factors as regulators of host defense. Annu. Rev. Immunol. 19 (2001) 623-655
66. Tsujimura H., Nagamura-Inoue T., Tamura T., and Ozato K. IFN consensus sequence binding protein/IFN regulatory factor-8 guides bone marrow progenitor cells toward the macrophage lineage. J. Immunol. 169 3 (2002) 1261-1269
67. Wang I.M., Contursi C., Masumi A., Ma X., Trinchieri G., and Ozato K. An IFN-gamma-inducible transcription factor, IFN consensus sequence binding protein (ICSBP), stimulates IL-12 p40 expression in macrophages. J. Immunol. 165 1 (2000) 271-279
68. Weisz A., Marx P., Sharf R., Appella E., Driggers P.H., Ozato K., and Levi B.Z. Human interferon consensus sequence binding protein is a negative regulator of enhancer elements common to interferon-inducible genes. J. Biol. Chem. 267 35 (1992) 25589-25596
69. Weisz A., Kirchhoff S., and Levi B.Z. IFN consensus sequence binding protein (ICSBP) is a conditional repressor of IFN inducible promoters. Int. Immunol. 6 8 (1994) 1125-1131
70. Yamada Y., Matsushiro H., Ogawa M.S., Okamoto K., Nakakuki Y., Toyokuni S., Fukumoto M., and Hiai H. Genetic predisposition to pre-B lymphomas in SL/Kh strain mice. Cancer Res 54 2 (1994) 403-407
71. Zhu C., Rao K., Xiong H., Gagnidze K., Li F., Horvath C., and Plevy S. Activation of the murine interleukin-12 p40 promoter by functional interactions between NFAT and ICSBP. J. Biol. Chem. 278 41 (2003) 39372-39382